StockData
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. (TPST) stock

TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.33−0.01 (-4.24%)

Close on Nov 17, 2026Market cap $4.85MP/E –Yield –

Tempest Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Tempest Therapeutics's market cap was $6.34M on Nov 11, 2026, against $14.21M a year earlier. Over the last 5 years it ranged from $3.83M to $86.20M, with a median of $22.30M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.34M-50.2%
2025Dec 31, 2025$12.74M-42.5%
2024Dec 31, 2024$22.17M-64.8%
2023Dec 29, 2023$63.03M+421.1%
2022Dec 30, 2022$12.10M-66.8%
2021Dec 31, 2021$36.44M-94.0%
2020Dec 31, 2020$609.88M-55.2%
2019Dec 31, 2019$1.36B+1494.1%
2018Dec 31, 2018$85.45M-62.0%
2017Dec 29, 2017$224.93M-8.2%
2016Dec 30, 2016$245.14M-79.6%
2015Dec 31, 2015$1.20B-74.7%
2014Dec 31, 2014$4.73B+574.1%
2013Dec 31, 2013$702.18M+49.7%
2012Dec 31, 2012$469.03M–

More Tempest Therapeutics figures

See a number that looks wrong?